Demyelinating diseases can affect both the central nervous system and peripheral nervous system.

The central nervous system (CNS), composed of the brain ... provides few treatment options for patients with CNS injuries or diseases. With only pharmacological treatments available that delay ...

The importance of the gut microbiome in central nervous system (CNS) diseases has long been recognized; however, research into this connection is limited, in part, owing to a lack of convincing ...

Get Instant Summarized Text (Gist) Metastatic brain cancer should be recognized as a distinct central nervous system (CNS) disease due to its unique molecular, genetic, and microenvironmental ...

The central nervous system (CNS) has very limited capacity to regenerate after traumatic injury or disease. In contrast, the peripheral nervous system (PNS ... Similar to Wallerian degeneration, these ...

For the WHO, the burden of brain disorders constitutes 35 to 38% of the total burden of all diseases (data based on DALYs: disability adjusted life years), compared to 12.7% for cancer and 11.8% ...

Background: Acute disseminated encephalomyelitis (ADEM) is a central nervous system demyelinating disease that usually follows an apparently benign infection in otherwise healthy young persons.

LPXTI-641 is under clinical development by Lapix Therapeutics and currently in Phase I for Demyelinating Diseases. According to GlobalData ... Lapix Therapeutics (Lapix) is a healthcare company that ...

CIDP treatment focuses on reducing and slowing the immune processes damaging your peripheral nervous system. It includes corticosteroids, intravenous immunoglobulin, and plasma exchange, but new ...

Jan. 28, 2025 — A new study explores the effects of both recent and lifetime cannabis use on brain function during cognitive tasks. The study, the largest of its kind ever to be completed ...